Metabolic effect of repaglinide or acarbose when added to a double oral antidiabetic treatment with sulphonylureas and metformin: a double-blind, cross-over, clinical trial

Giuseppe Derosa, Sibilla A. T. Salvadeo, Angela D’Angelo, Ilaria Ferrari, Roberto Mereu, Ilaria Palumbo, Pamela Maffioli, Sabrina Randazzo, Arrigo F. G. Cicero
  • Current Medical Research and Opinion, January 2009, Informa Healthcare
  • DOI: 10.1185/03007990802711024

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1185/03007990802711024

The following have contributed to this page: Dr Arrigo FG CICERO